ArticleCancer research communications2022

Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.

Julia I Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.